In HNSCC patients receiving platinum therapy (n = 14), we identified a novel TSD+ CSC and TSD+ CTC phenotype characterized by the transient expansion and expression of TSD+ phenotype in EpCAM+/ABCG2+ CSCs. The gene discussed is HEXA; the disease is head and neck squamous cell carcinoma.